Higher Levels of Autoantibodies Targeting Mutated Citrullinated Vimentin in Patients with Psoriatic Arthritis Than in Patients with Psoriasis Vulgaris
Antibodies against citrullinated proteins/peptides (ACPAs), and especially antibodies targeting mutated citrullinated vimentin (anti-MCVs), are novel biomarkers of rheumatoid arthritis (RA). Whereas ACPAs are specific and sensitive markers for RA, there have hardly been any reports relating to ACPAs...
Main Authors: | Szandra Dalmády, Mária Kiss, László Képíró, László Kovács, Gábor Sonkodi, Lajos Kemény, Rolland Gyulai |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2013-01-01
|
Series: | Clinical and Developmental Immunology |
Online Access: | http://dx.doi.org/10.1155/2013/474028 |
Similar Items
-
The association of HLA-C and ERAP1 polymorphisms
in early and late onset psoriasis and psoriatic arthritis
patients of Hungary
by: László Képíró, et al.
Published: (2021-03-01) -
Characterization of patients with anti-modified citrullinated vimentin antibodies (MCVA)
by: Ruiz-Ortiz de Arrizabaleta Estíbaliz, et al.
Published: (2011-11-01) -
Clinical Relevance of Autoantibodies in Patients with Autoimmune Bullous Dermatosis
by: Lilla Mihályi, et al.
Published: (2012-01-01) -
Assessment of serum antimutated citrullinated vimentin antibodies in rheumatoid arthritis
by: Refaat M El Tanawy, et al.
Published: (2015-01-01) -
Evaluation of Anti-Mutated Citrullinated Vimentin Antibodies, Anti-Cyclic Citrullinated Peptide Antibodies and Rheumatoid Factor in Omani Patients with Rheumatoid Arthritis
by: Ahmed Al-Shukaili, et al.
Published: (2012-01-01)